Medifast (MED) Expected to Release Earnings on Monday

Medifast (NYSE:MED) is anticipated to post its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Medifast to post earnings of ($0.01) per share and revenue of $84.10 million for the quarter. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS.Individuals may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Monday, November 3, 2025 at 4:30 PM ET.

Medifast (NYSE:MED) last posted its earnings results on Monday, August 4th. The specialty retailer reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.22) by $0.26. Medifast had a return on equity of 2.00% and a net margin of 0.76%.The firm had revenue of $105.56 million for the quarter, compared to analyst estimates of $96.10 million. On average, analysts expect Medifast to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Medifast Price Performance

Medifast stock opened at $12.06 on Friday. The stock has a market cap of $132.48 million, a PE ratio of 37.67 and a beta of 0.85. The stock’s fifty day moving average is $13.57 and its two-hundred day moving average is $13.52. Medifast has a 1-year low of $11.57 and a 1-year high of $21.98.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Medifast in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $16.50.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Man Group plc lifted its stake in Medifast by 0.6% in the second quarter. Man Group plc now owns 198,156 shares of the specialty retailer’s stock valued at $2,784,000 after buying an additional 1,200 shares during the last quarter. Bank of America Corp DE grew its position in shares of Medifast by 37.4% during the second quarter. Bank of America Corp DE now owns 396,369 shares of the specialty retailer’s stock worth $5,569,000 after acquiring an additional 107,854 shares during the last quarter. Engineers Gate Manager LP acquired a new position in shares of Medifast in the 2nd quarter valued at $161,000. Prudential Financial Inc. purchased a new stake in Medifast in the 2nd quarter valued at $200,000. Finally, Caption Management LLC acquired a new stake in Medifast during the 2nd quarter worth $244,000. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.